Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

ZANTAC HEARTBURN MEDICATION Legal News Articles & Interviews

FDA Pulls Zantac off Shelves

FDA Pulls Zantac off Shelves July 6, 2020. By Anne Wallace.
Washington, DC On April 1, the federal Food and Drug Administration asked manufacturers to withdraw Zantac and all other prescription and over-the-counter ranitidine drugs from the market immediately. It has also advised those who use OTC ranitidine medications to stop taking them immediately and patients with ranitidine prescriptions to speak with their health care providers. Zantac cancer lawsuits that cite the link between heartburn medications that contain ranitidine and various forms of cancer have been forming for months. The FDA has now finally taken affirmative steps to protect consumers.

Read [ FDA Pulls Zantac off Shelves ]

Two Zantac Lawsuits, Two types of Cancer

Two Zantac Lawsuits, Two types of Cancer June 12, 2020. By Jane Mundy.
Tampa, FL Two Zantac lawsuits recently filed allege the popular heartburn and acid reflux medication causes Zantac bladder cancer and Zantac colon cancer. Both plaintiffs claim they were exposed to dangerous amounts of  N--Nitrosodimethylamine (NDMA), a known cancer-causing chemical found in the medication.
Read [ Two Zantac Lawsuits, Two types of Cancer ]

Zantac Associated with Breast Cancer

Zantac Associated with Breast Cancer May 20, 2020. By Jane Mundy.
Santa Clara, CA Several Zantac breast cancer lawsuits have been filed against the drug manufacturers, 12 years after a peer-reviewed study from the Fred Hutchinson Cancer Research Center linked Zantac with breast cancer.
Read [ Zantac Associated with Breast Cancer ]

FDA Finally Pulls Zantac

FDA Finally Pulls Zantac April 17, 2020. By Jane Mundy.
Washington, DC Since at least last summer the FDA has known that a contaminant known as N-Nitrosodimethylamine (NDMA) was present in ranitidine medications (commonly known as the brand name Zantac), but the agency didn’t order a withdrawal of the popular heartburn drug until this month – almost a year later. Chances are, countless people who have been taking a side of a potential carcinogen with their Zantac dose each day are concerned about the possibility of developing Zantac-related cancer —and many people are filing Zantac lawsuits.
Read [ FDA Finally Pulls Zantac ]

Zantac Cancer Lawsuits Move to MDL Phase

Zantac Cancer Lawsuits Move to MDL Phase March 20, 2020. By Anne Wallace.
West Palm Beach, FL Zantac cancer lawsuits will be consolidated in multidistrict litigation in the U.S. District Court for the Southern District of Florida. At the time of its formation on February 6, the MDL included 15 cases. An additional 126 cases were pending in 21 districts nationwide, and more plaintiffs are expected to join. The consolidated lawsuit will include cancer injury claims and consumer class actions against defendants who manufactured, sold or distributed Zantac and other ranitidine medications.
Read [ Zantac Cancer Lawsuits Move to MDL Phase ]

Rantidine Recalls Stoke Zantac Cancer Lawsuits

Rantidine Recalls Stoke Zantac Cancer Lawsuits February 12, 2020. By Anne Wallace.
Washington, DC A cascade of recalls – by Sanofi, the manufacturer of Zantac and a collection of pharmacies that distribute the heartburn drug – is fuel to the fire of the Zantac cancer lawsuits now forming. Lawyers reportedly anticipate an explosion of Zantac lawsuits over the next several months.
Read [ Rantidine Recalls Stoke Zantac Cancer Lawsuits ]

New Research: Brief Heat Exposure Increases Zantac Cancer Odds

New Research: Brief Heat Exposure Increases Zantac Cancer Odds January 14, 2020. By Anne Wallace.
Washington, DC Emery Pharma, a California-based testing laboratory has reported that Zantac appears to produce unacceptably high levels of cancer-causing N-Nitrosodimethylamine (NDMA) when exposed to heat for as little as five days. Brief periods of modestly inadequate temperature control can easily occur during transport, storage or even in consumer’s home. These findings have sparked new calls for a U.S. Food and Drug Administration recall of Zantac and related generic drugs and will likely fuel class action Zantac cancer lawsuits (ZANTAC) already underway.
Read [ New Research: Brief Heat Exposure Increases Zantac Cancer Odds ]

More Ranitidine Cancer Concerns Lead to Zantac Lawsuits

More Ranitidine Cancer Concerns Lead to Zantac Lawsuits January 9, 2020. By Jane Mundy.
Santa Clara, CA Since the FDA last September reported that minute amounts of a carcinogen called N-nitrosodimethylamine (NDMA) was detected in Zantac, along with several other heartburn medications, a number of Zantac cancer lawsuits have followed.
Read [ More Ranitidine Cancer Concerns Lead to Zantac Lawsuits ]

Zantac – Buyer Beware, but from Whom?

Zantac – Buyer Beware, but from Whom? December 9, 2019. By Jane Mundy.
Santa Clara, CA Since the small pharmacy Valisure waved the red flag over Zantac cancer risk, over 40 countries worldwide have stopped sales and/or began investigating the possible health risks of the heartburn drug. And Zantac lawsuits have followed. Now the FDA says it is “investigating”.
Read [ Zantac – Buyer Beware, but from Whom? ]

More Zantac Cancer Lawsuits and Recalls

More Zantac Cancer Lawsuits and Recalls November 19, 2019. By Jane Mundy.
Santa Clara, CA As more pharmaceutical companies are hit with Zantac cancer lawsuits, they are recalling the acid reflux medication in the U.S. and Canada over complaints of a link to a probable carcinogen called called N-nitrosodimethylamine (NDMA), a chemical that has already been found in animals.
Read [ More Zantac Cancer Lawsuits and Recalls ]


Request Legal Help Now! - Free